These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11179069)

  • 1. Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression.
    Huber JD; Witt KA; Hom S; Egleton RD; Mark KS; Davis TP
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1241-8. PubMed ID: 11179069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.
    Huber JD; Hau VS; Borg L; Campos CR; Egleton RD; Davis TP
    Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1531-7. PubMed ID: 12234806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant.
    Huber JD; Hau VS; Mark KS; Brown RC; Campos CR; Davis TP
    Eur J Pharmacol; 2002 Aug; 450(3):297-304. PubMed ID: 12208323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hypoxia-reoxygenation on rat blood-brain barrier permeability and tight junctional protein expression.
    Witt KA; Mark KS; Hom S; Davis TP
    Am J Physiol Heart Circ Physiol; 2003 Dec; 285(6):H2820-31. PubMed ID: 12907427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations.
    Brooks TA; Hawkins BT; Huber JD; Egleton RD; Davis TP
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H738-43. PubMed ID: 15792985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain.
    Brooks TA; Ocheltree SM; Seelbach MJ; Charles RA; Nametz N; Egleton RD; Davis TP
    Brain Res; 2006 Nov; 1120(1):172-82. PubMed ID: 17007822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier.
    Campos CR; Ocheltree SM; Hom S; Egleton RD; Davis TP
    Brain Res; 2008 Jul; 1221():6-13. PubMed ID: 18554577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain.
    Lochhead JJ; McCaffrey G; Sanchez-Covarrubias L; Finch JD; Demarco KM; Quigley CE; Davis TP; Ronaldson PT
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H582-93. PubMed ID: 22081706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia.
    McCaffrey G; Seelbach MJ; Staatz WD; Nametz N; Quigley C; Campos CR; Brooks TA; Davis TP
    J Neurochem; 2008 Sep; 106(6):2395-409. PubMed ID: 18647175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain.
    Ronaldson PT; Demarco KM; Sanchez-Covarrubias L; Solinsky CM; Davis TP
    J Cereb Blood Flow Metab; 2009 Jun; 29(6):1084-98. PubMed ID: 19319146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution.
    Hawkins BT; Abbruscato TJ; Egleton RD; Brown RC; Huber JD; Campos CR; Davis TP
    Brain Res; 2004 Nov; 1027(1-2):48-58. PubMed ID: 15494156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diclofenac attenuates the regional effect of lambda-carrageenan on blood-brain barrier function and cytoarchitecture.
    Brooks TA; Nametz N; Charles R; Davis TP
    J Pharmacol Exp Ther; 2008 May; 325(2):665-73. PubMed ID: 18305016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo.
    McCaffrey G; Staatz WD; Quigley CA; Nametz N; Seelbach MJ; Campos CR; Brooks TA; Egleton RD; Davis TP
    J Neurochem; 2007 Dec; 103(6):2540-55. PubMed ID: 17931362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The tight junction proteins ZO-1, occludin and actin participate in the permeability increasing of blood-brain barrier induced by hypoxia-ischemia].
    Wu LW; Yin F; Peng J; Wang WD; Gan N
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):513-6. PubMed ID: 18706176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age and 17β-estradiol effects on blood-brain barrier tight junction and estrogen receptor proteins in ovariectomized rats.
    Sandoval KE; Witt KA
    Microvasc Res; 2011 Mar; 81(2):198-205. PubMed ID: 21192956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.
    Hawkins BT; Lundeen TF; Norwood KM; Brooks HL; Egleton RD
    Diabetologia; 2007 Jan; 50(1):202-11. PubMed ID: 17143608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation.
    Lochhead JJ; McCaffrey G; Quigley CE; Finch J; DeMarco KM; Nametz N; Davis TP
    J Cereb Blood Flow Metab; 2010 Sep; 30(9):1625-36. PubMed ID: 20234382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
    András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M
    J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
    Musch MW; Walsh-Reitz MM; Chang EB
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    Liu LB; Xue YX; Liu YH; Wang YB
    J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.